Clinical trial

APOLLO(Aromatase Inhibitor Patient cOmpLiance Program With qoL Questionaire)

NCT00523315

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2007-05-01

PhaseN/A

Study timeline

Study start (unknown)2007-05-01Date precision: month

Registry last updated2011-05-20

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Interventions

Sponsors & collaborators

AstraZenecalead sponsor

Mapped research locations

SeoulSouth Korea1 IncheonSouth Korea1 DaeguSouth Korea1 BusanSouth Korea1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00523315 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.